We serve Chemical Name:1-(4-Acetylphenyl)pyrrolidin-2-one CAS:682351-65-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(4-Acetylphenyl)pyrrolidin-2-one
CAS.NO:682351-65-1
Synonyms:1-(4-Acetylphenyl)pyrrolidin-2-one
Molecular Formula:C12H13NO2
Molecular Weight:203.23700
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:37.38000
Exact Mass:203.09500
LogP:2.08100
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-(4-Acetylphenyl)pyrrolidin-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(4-Acetylphenyl)pyrrolidin-2-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(4-Acetylphenyl)pyrrolidin-2-one Use and application,1-(4-Acetylphenyl)pyrrolidin-2-one technical grade,usp/ep/jp grade.
Related News: Johnson & Johnson’s COVID-19 vaccine presents greater benefits than it does safety risks, especially amid the quickly spreading Delta variant, a key CDC expert panel decided. However, the panel said that a ruling over the need for a booster added to all COVID shots will have to start with the FDA. 2-((3-methylbenzo[4,5]imidazo[2,1-b]thiazol-2-yl)methyl)isoindoline-1,3-dione manufacturers After the IPO, he now owns a 53% stake, worth $3.1 billion, plus roughly $100 million in cash and other investments, including a winery in northeastern Italy. His sons Franco and Marco (the company’s vice chairman) each own 12% stakes worth about $730 million apiece. benzyl ((2S)-4-methyl-1-oxo-1-((3-oxo-1-phenylbutan-2-yl)amino)pentan-2-yl)carbamate suppliers Grégoire holds a Masters’ degree in Fundamental Physics from Pierre and Marie Curie University. Transcription factor PCF1 (rice clone pGAD-PCF1 gene PCF1) vendor & factory Grégoire Boutonnet, Chief Operating Officer of NOVA, said: “I am thrilled to be joining the NOVA team at this exciting period of growth as we launch the Jinkō platform towards wider adoption in the clinical trial development space. ,Grégoire holds a Masters’ degree in Fundamental Physics from Pierre and Marie Curie University.
